Latest News and Press Releases

Zenas BioPharma investors are encouraged to call Cohen Milstein's Molly Bowen, Esq. about becoming a lead plaintiff in the ZBIO stock drop class action.

Cohen Milstein continues lead plaintiff Search for Zenas BioPharma (ZBIO) securities fraud class action. Contact Molly Bowen, Esq. at 1 (202) 408-4600.

Cohen Milstein reminds Zenas BioPharma (ZBIO) investors of an opportunity to lead a securities fraud class action. Lead plaintiff deadline - June 16, 2025.

Cohen Milstein seeks Zenas BioPharma (ZBIO) investors to join and/or lead class action to hold Zenas BioPharma accountable for IPO-related fraud.

Cohen Milstein Encourages Zenas BioPharma Investors Who Lost Money Following IPO Stock Collapse to Call Firm to Potentially Join or Lead Class Action.

Investors who purchased stock in Zenas BioPharma, Inc. (NASDAQ: ZBIO) September 2024 IPO and lost money should call Cohen Milstein to join a class action.

WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO) who bought shares in the company’s September 2024 IPO may be eligible to participate in and lead a...

Zenas Biopharma Investors Urged to Contact Cohen Milstein After Post-IPO Losses

PERION NETWORK LTD. (NASDAQ: $PERI) - Investor Alert: DiCello Levitt LLP Encourages Investors to Retain Counsel Before Class Action Deadline.

NEW YORK, Jan. 13, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. a preeminent law firm in obtaining redress for investors, is investigating breaches of fiduciary duties involving the directors and...